High Red Blood Folate Levels Linked to Silenced Tumor-Suppressors
Study examines effects of supplementation, other factors, on gene methylation
MD Anderson News Release 12/22/2010
People with higher levels of folate in their red blood cells were more likely to have two tumor-suppressing genes shut down by methylation, a chemical off switch for genes, researchers report in the December issue of Cancer Prevention Research.
DNA hypermethylation, notes co-author Jean-Pierre Issa, M.D...
Protein Disables p53, Drives Breast Cells Toward Cancer Transition
High expression of TRIM24 is common in breast cancer, correlates with poor survival
MD Anderson News Release 12/15/10
The recently...
Alcohol and Cancer: Know Your Limit
MD Anderson Encourages Holiday Partygoers to Practice Mindful Behavior
MD Anderson News Release 12/13/2010
When raising...
Poor Breast Cancer Prognosis Associated With Presence of Circulating Tumor, Cancer Stem Cells
Research shows cells' effect on survival of metastatic breast cancer patients treated with high-dose chemotherapy and stem cell transplant
MD Anderson News Release 12/10/10
Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with high-dose chemotherapy and blood stem cell transplant have shorter survival periods, according to a new study by researchers at The...
Drugs are Safe, Active in Patients Normally Ineligible for Clinical Trial
Combination given to AML, MDS patients who have second disease and no options
MD Anderson News Release 12/10/10
A two-drug combination...
Cancer Prevention Expert Honored for Innovative Tobacco Research
National program recognizes UT MD Anderson scientist Alexander Prokhorov
MD Anderson News Release 12/09/10
Behavioral scientist...
Small Molecule May Disarm Enemy of Cancer-Fighting p53
First clinical trial looks at RG7112 as a way to disable MDM2 in leukemia
MD Anderson News Release 12/07/10
A pioneering clinical...
After 15 Years, Mendelsohn to Change Role
John Mendelsohn, M.D., who has served as president of The University of Texas
MD Anderson Cancer Center through an incredibly...
Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML
Drug also acts against chronic myeloid leukemia with untreatable T315I mutation
MD Anderson News Release 12/04/10
A new drug...
UT MD Anderson Cancer Center Honors Legendary Journalist Bob Schieffer
Annual Dallas/FortWorth Fundraiser Features Interview With NBC's Tom Brokaw
MD Anderson News Release 12/03/10
HOUSTON - A Conversation...